Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2014

Jan 4, 2014

29875_dirs_2014-01-03_c9a1decb-cafd-4447-af84-bf617cbe06d5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2014-01-02

Reporting Person: Lofberg Per GH (EVP and President, Caremark)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-02 Common Stock M 401706 $32.98 Acquired 448106 Direct
2014-01-02 Common Stock S 401706 $70.58 Disposed 46400 Direct
2014-01-03 Common Stock M 234066 $34.96 Acquired 280466 Direct
2014-01-03 Common Stock S 234066 $70.47 Disposed 46400 Direct
2014-01-03 Common Stock M 101992 $36.23 Acquired 148392 Direct
2014-01-03 Common Stock S 101992 $70.47 Disposed 46400 Direct
2014-01-03 Common Stock M 53124 $32.98 Acquired 99524 Direct
2014-01-03 Common Stock S 53124 $70.61 Disposed 46400 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-02 Stock Option $32.98 M 401706 Disposed 2020-01-03 Common Stock (401706) Direct
2014-01-02 Stock Option $70.40 A 112181 Acquired 2021-01-02 Common Stock (112181) Direct
2014-01-03 Stock Option $34.96 M 234066 Disposed 2018-04-01 Common Stock (234066) Direct
2014-01-03 Stock Option $36.23 M 101992 Disposed 2017-04-01 Common Stock (101992) Direct
2014-01-03 Stock Option $32.98 M 53124 Disposed 2020-01-03 Common Stock (53124) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 162000 Indirect
Common Stock 14400 Indirect
Stock Unit 219870.5883 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $45.07 2019-12-31 Common Stock (347343) 347343 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share.

F3: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share.

F4: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share.

F5: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.43 and $70.75 per share.

F6: Option became exercisable on 12/31/2012.

F7: Option becomes exercisable on December 31, 2014.

F8: Option became exercisable on 12/31/2012.

F9: The Option becomes exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company.

F10: Option became exercisable on December 31, 2013.